About Altos Labs
Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.
Headquarters
Altos Labs, San Francisco
Founded
2021-04-15
Industry
Biopharma, Biotechnology, Health Care, Health Diagnostics, Medical
Last Funding Type
Series A
Valuation
3
Total Funding
$3.00 billion dollars
IPO Status
Private
Financial
Altos Labs' Co-founder and Chief Scientist discussed the success of Yamanaka factors in rejuvenation research at the Aspen Ideas Health Conference. Additionally, the president and co-founder of Altos Labs has stepped down from the board of directors of Agilent Technologies.
Funding Rounds
1
Total Funding Amount
$3.00 billion dollars
Number of Investors
1